Synthesis, Crystal and Molecular Structure of Novel Adamantyl Derivatives of N-Aryl Substituted 3-Hydroxy-2-methylpyridine-4-ones

被引:3
作者
Perokovic, Vesna Petrovic [1 ]
Prugovecki, Biserka [1 ]
Car, Zeljka [1 ]
机构
[1] Univ Zagreb, Fac Sci, Dept Chem, Zagreb 10000, Croatia
关键词
adamantan-1-ylacetic acid; 3-hydroxypyridine-4-ones; single crystal X-ray diffraction; Steglich esterification; PHYSICAL-PROPERTIES; ANTITUMOR-ACTIVITY; DISEASE; DESIGN; ACID;
D O I
10.5562/cca2339
中图分类号
O6 [化学];
学科分类号
0703 ;
摘要
Two novel potentially bioactive compounds, esters 2-methyl-1-phenylpyridine-4-one-3-yl adamantan-1-ylethanoate (1) and 1-(p-methoxyphenyl)-2-methylpyridine-4-one-3-yl adamantan-1-ylethanoate (2), were synthesized by esterification of adamantan-l-ylacetic acid with appropriate N-aryl substituted 3-hydroxypyridine-4-one derivatives. Both compounds are fully characterized using standard spectroscopic methods. Crystal and molecular structures of 1 and 2 were determined by the single crystal X-ray diffraction method. The crystal packing of both 1 and 2 shows separation of the hydrophobic and hydrophilic regions. The crystal structure of 1 is characterized by the two-dimensional hydrogen bonding layers parallel to (001). The crystal packing of 2 is characterized by hydrogen-bonded chains extended in the direction [010].
引用
收藏
页码:317 / 323
页数:7
相关论文
共 36 条
[1]   The Cambridge Structural Database: a quarter of a million crystal structures and rising [J].
Allen, FH .
ACTA CRYSTALLOGRAPHICA SECTION B-STRUCTURAL SCIENCE, 2002, 58 (3 PART 1) :380-388
[2]  
ALLEN FH, CAMBRIDGE STRUCTURAL
[3]  
[Anonymous], XCAL CCD SYST CRYSAL
[4]   Adamantane-retropeptides, new building blocks for molecular channels [J].
Basaric, Nikola ;
Molcanov, Kresimir ;
Matkovic, Marija ;
Kojic-Prodic, Biserka ;
Mlinaric-Majerski, Kata .
TETRAHEDRON, 2007, 63 (33) :7985-7996
[5]   Inhibition of HIV-1 replication by newly developed adamantane-containing polyanionic agents [J].
Burstein, ME ;
Serbin, AV ;
Khakhulina, TV ;
Alymova, IV ;
Stotskaya, LL ;
Bogdan, OP ;
Manukchina, EE ;
Jdanov, VV ;
Sharova, NK ;
Bukrinskaya, AG .
ANTIVIRAL RESEARCH, 1999, 41 (03) :135-144
[6]  
CHIMIRRI A, 1994, FARMACO, V49, P649
[7]  
El-Sherbeny MA, 2000, ARCH PHARM, V333, P323, DOI 10.1002/1521-4184(200010)333:10<323::AID-ARDP323>3.3.CO
[8]  
2-L
[9]  
Farrugia L. J., 1999, Journal of Applied Crystallography, V32, P837, DOI [DOI 10.1107/S0021889812029111, 10.1107/S0021889899006020, DOI 10.1107/S0021889899006020]
[10]  
FYTAS G, 1994, FARMACO, V49, P641